STCube, Inc. 052020.KQ Stock
STCube, Inc. Price Chart
STCube, Inc. 052020.KQ Financial and Trading Overview
STCube, Inc. stock price | 4915 KRW |
Previous Close | 15800 KRW |
Open | 15930 KRW |
Bid | 16320 KRW x 0 |
Ask | 16060 KRW x 0 |
Day's Range | 15710 - 16340 KRW |
52 Week Range | 4745 - 28500 KRW |
Volume | 408.3K KRW |
Avg. Volume | 776.25K KRW |
Market Cap | 437.18B KRW |
Beta (5Y Monthly) | 0.078119 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
052020.KQ Valuation Measures
Enterprise Value | 684.75B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 67.38621 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 105.545 |
Enterprise Value/EBITDA | -33.623 |
Trading Information
STCube, Inc. Stock Price History
Beta (5Y Monthly) | 0.078119 |
52-Week Change | 186.75% |
S&P500 52-Week Change | 20.43% |
52 Week High | 28500 KRW |
52 Week Low | 4745 KRW |
50-Day Moving Average | 18921.2 KRW |
200-Day Moving Average | 18096.25 KRW |
052020.KQ Share Statistics
Avg. Volume (3 month) | 776.25K KRW |
Avg. Daily Volume (10-Days) | 735.15K KRW |
Shares Outstanding | 26.76M |
Float | 39.99M |
Short Ratio | N/A |
% Held by Insiders | 4.17% |
% Held by Institutions | 5.87% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -330.98% |
Gross Margin | 2.24% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -28.57% |
Return on Equity (ttm) | -57.063% |
Income Statement
Revenue (ttm) | 6.49B KRW |
Revenue Per Share (ttm) | 180.76 KRW |
Quarterly Revenue Growth (yoy) | -31.30% |
Gross Profit (ttm) | 7.85M KRW |
EBITDA | -20365346816 KRW |
Net Income Avi to Common (ttm) | -20959860736 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 53.35B KRW |
Total Cash Per Share (mrq) | 1207.84 KRW |
Total Debt (mrq) | 2.64B KRW |
Total Debt/Equity (mrq) | 4.92 KRW |
Current Ratio (mrq) | 19.791 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -17086241792 KRW |
Levered Free Cash Flow (ttm) | -10991087616 KRW |
Profile of STCube, Inc.
Country | South Korea |
State | N/A |
City | Seoul |
Address | #2201, Korea World Trade Center Trade Tower |
ZIP | 06164 |
Phone | 82 2 551 3370 |
Website | https://www.stcube.com |
Industry | |
Sector(s) | |
Full Time Employees | 12 |
STCube, Inc., a biopharmaceutical company, develops therapies to treat novel immune evasion mechanisms in cancer in South Korea. Its platforms include STGlyTarget that is used for the identification and development of immunomodulatory proteins; Immunomodulator Discovery Platform, a proprietary technology to screen for immunomodulatory proteins; Glyco-Specific Antibody Development Platform, a technology designed to screen for antibodies that selectively mask specific sites of target proteins; and Glyco-Specific Antibody Characterization and Optimization Platform, a technology designed to optimize characteristics exerted by antibodies that mask specific sites of target proteins. The company's product pipeline consists of various anti-cancer drugs, including programmed death ligand 1, a type of protein, which is expressed in cancer cells and interferes with the natural tumor killing of immune cells; programmed death-1, a type of protein that is expressed in T cells; and cytotoxic T-lymphocyte associated protein 4, a protein that inhibits the activity of T-cells that can kill cancer cells. Its product pipeline also comprises lymphocyte-activation gene 3, a type of protein, which exists in the cell membrane of immune cells, such as T-cells and NK cells. The company was formerly known as Schem Co., Ltd. and changed its name to STCube, Inc. in April 2008. STCube, Inc. was founded in 1989 and is headquartered in Seoul, South Korea.
Q&A For STCube, Inc. Stock
What is a current 052020.KQ stock price?
STCube, Inc. 052020.KQ stock price today per share is 4915 KRW.
How to purchase STCube, Inc. stock?
You can buy 052020.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for STCube, Inc.?
The stock symbol or ticker of STCube, Inc. is 052020.KQ.
How many shares does STCube, Inc. have in circulation?
The max supply of STCube, Inc. shares is 46.23M.
What is STCube, Inc. Price to Earnings Ratio (PE Ratio)?
STCube, Inc. PE Ratio is now.
What was STCube, Inc. earnings per share over the trailing 12 months (TTM)?
STCube, Inc. EPS is 0 KRW over the trailing 12 months.